Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Biotechs feel the pain

The biotechnology industry is weathering the financial crisis better than some. That doesn't mean it's in great shape, reports Heidi Ledford.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout


Additional information

For more of Nature's coverage on how the recession affects science, see our special

Related links

Related links

Related links in Nature Research

Special: Recession Watch

Nature Biotechnology

Nature Reviews Drug Discovery

Related external links

Biotechnology Industry Organization

Massachusetts Biotechnology Council

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ledford, H. Biotechs feel the pain. Nature 457, 136–137 (2009).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing